Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$101,522
+$49,913 QoQ
Shares Held
7,498
-13.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#270
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Steward Partners Investment Advisory, LLC holds $502,917,200 across 18 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
116,568 | $139,815,167 | |
| 2 | ABBV |
AbbVie Inc.
|
475,389 | $119,626,887 | |
| 3 | JNJ |
Johnson & Johnson
|
461,457 | $117,196,234 | |
| 4 | MRK |
Merck & Co., Inc.
|
318,918 | $40,980,963 | |
| 5 | AMGN |
Amgen Inc
|
79,642 | $28,839,961 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
277,131 | $15,968,288 | |
| 7 | PFE |
Pfizer Inc
|
520,623 | $12,536,601 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
66,698 | $8,426,625 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,522 | 7,498 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $51,609 | 8,616 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $62,113 | 8,663 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $98,127 | 9,188 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $85,261 | 8,808 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $148,349 | 9,963 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $148,006 | 9,920 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $213,509 | 11,161 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $131,134 | 6,335 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $93,849 | 4,992 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $79,151 | 5,489 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $135,078 | 7,781 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $170,017 | 8,170 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $191,946 | 8,161 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $254,833 | 9,124 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $236,433 | 10,104 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $512,460 | 15,184 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $573,341 | 16,414 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $561,132 | 18,428 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $837,030 | 25,527 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $885,316 | 29,257 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||